News
ZLAB
29.54
+21.46%
5.22
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Benzinga · 1d ago
Zai Lab (ZLAB) Gets a Buy from Scotiabank
TipRanks · 1d ago
Zai Lab management to meet with Cantor Fitzgerald
TipRanks · 5d ago
Zai Lab (ZLAB) Gets a Buy from Scotiabank
TipRanks · 5d ago
Weekly Report: what happened at ZLAB last week (0331-0404)?
Weekly Report · 5d ago
Weekly Report: what happened at ZLAB last week (0324-0328)?
Weekly Report · 03/31 11:27
Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday
Benzinga · 03/28 13:52
Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday
Benzinga · 03/27 14:15
Cantor Fitzgerald Reiterates Overweight on Zai Labto Overweight
Benzinga · 03/27 13:10
Weekly Report: what happened at ZLAB last week (0317-0321)?
Weekly Report · 03/24 11:15
Zai Lab’s Stable Growth and Competitive Challenges Justify Hold Rating
TipRanks · 03/24 10:55
Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth
Seeking Alpha · 03/21 21:16
Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks
Seeking Alpha · 03/20 17:05
Weekly Report: what happened at ZLAB last week (0310-0314)?
Weekly Report · 03/17 11:26
Zai Lab Is Maintained at Overweight by JP Morgan
Dow Jones · 03/13 20:26
Zai Lab Price Target Raised to $51.00/Share From $44.00 by JP Morgan
Dow Jones · 03/13 20:26
JP Morgan Maintains Overweight on Zai Lab, Raises Price Target to $51
Benzinga · 03/13 20:16
Zai Lab gets China review for Pfizer-partnered cervical cancer therapy
Seeking Alpha · 03/13 11:20
Zai Lab : China Accepts TIVDAK BLA For Treatment Of Recurrent Or Metastatic Cervical Cancer
NASDAQ · 03/13 00:55
ZAI LAB ANNOUNCES ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION FOR TIVDAK FOR THE TREATMENT OF PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER
Reuters · 03/12 23:30
More
Webull provides a variety of real-time ZLAB stock news. You can receive the latest news about Zai Lab Limited through multiple platforms. This information may help you make smarter investment decisions.
About ZLAB
More
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.